Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1996

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Mixture

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

DRUG BANK

1

EPA CompTox

1

EVMPD

1

FDA UNII

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

BLOOD AND BLOOD FORMING ORGANS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTITHROMBOTIC AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

ANTITHROMBOTIC AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Heparin group

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|ANTITHROMBOTIC AGENTS|ANTITHROMBOTIC AGENTS|Heparin group|danaparoid" in comments (approximate match)

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DANAPAROID

BI6GY4U9CW

Status:

US Previously Marketed

First approved in 1996

Class:

MIXTURE

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1